Jefferies Financial Group’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
Jefferies Financial Group's ABVX Position: Q3 2026 in Review
Jefferies Financial Group increased its Abivax (ABVX) stake by 3,436% in Q3 2026, buying an estimated $19.8M and bringing the position to 168,705 shares worth $16.7M. The position accounts for 0.12% of the portfolio, ranked #139.
Jefferies Financial Group first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. The position peaked at $61.7M in Q4 2025. 124 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Jefferies Financial Group held 168,705 shares of Abivax worth $16.7M as of Q3 2026.
- Jefferies Financial Group bought 163,934 Abivax shares in Q3 2026, an estimated $19.8M.
- Abivax made up 0.12% of Jefferies Financial Group's portfolio in Q3 2026, its #139 holding.
- Jefferies Financial Group first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
- Jefferies Financial Group's Abivax position peaked at $61.7M in Q4 2025.
- 124 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.